Clinical Trial 42074

Atlanta, GA 30342


Study Summary:

The purpose of this research study is to evaluate the next-dose trasnition from Zolpidem (Ambien) to Lemborexant for the treatment of insomnia.


Qualified Participants Must:

• Be 18 years or older, currently taking Zolpidem (Ambien) and spend more than 7 hours a night in bed


Qualified Participants May Receive:

Up to $500


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.